Skip to content

Clinical Application of Peri-Operative Management Pathway Oriented to Enhanced Postoperative Recovery

Clinical Application of Peri-Operative Management Pathway Oriented to Enhanced Postoperative Recovery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055553
Enrollment
Unknown
Registered
2022-01-12
Start date
2022-01-17
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Experimental group:Non-intubated general anesthesia
Control group:None

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. ASA classification I-II grade; 3. Diagnosed with early to medium-term non-small cell lung cancer (stage I to II); 4. Elective VATS-L surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients who undergo emergency surgery; 2. Contraindications to various punctures or nerve blocks in the peri-operative period; 3. Contraindications to non-intubated general anesthesia; 4. Patients who relapse after treatment of lung cancer or meet the contraindications to surgery; 5. Pregnant and lactating women; 6. Severe systemic diseases (such as uncontrolled hypertension, diabetes, cachexia, etc.); 7. People with a history of alcoholism, drug dependence, and illicit drug use; 8. Patients participating in other clinical studies within 3 months before surgery.

Design outcomes

Primary

MeasureTime frame
Length of hospital stay;

Countries

China

Contacts

Public ContactChen Lu

The First Affiliated Hospital of Fujian Medical University

165552215@qq.com+86 15806090955

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026